The commencement ceremony of pumis biopharmaceutical project undertaken by the group was held
Release time:
2021-07-30
The commencement ceremony of pumis biopharmaceutical project undertaken by the group was held
On July 30, the commencement ceremony of Nantong pumis biopharmaceutical phase I EPC project undertaken by the group company was held at the project site of Nantong Economic Development Zone. The project won the bid at the end of June. At present, the project department has basically completed the construction of temporary facilities, water and electricity, is in the process of site surface clearing, and is about to carry out foundation construction. It is expected to complete the main construction tasks in 8 months, and will be completed and put into operation by the end of 2022. Yin Weibiao, deputy general manager of the group company and head of Maosheng international engineering branch, delivered a speech at the commencement ceremony. He said that Jiangsu Qi'an has rich experience in pharmaceutical project construction, has successfully cooperated with well-known pharmaceutical enterprises at home and abroad for many times, and will keep pace with the times and actively innovate in the construction in combination with the experience of previous projects; At the same time, it will also perform the responsibilities of the general contractor, actively coordinate, carefully organize, closely cooperate and strictly manage, and create an industry benchmark project for the owner and local government with first-class service and construction. He Bingyan, the representative of the owner pumis, and Ni Shihua, the representative of project management bean, delivered speeches successively. Guan Zhuoming, senior vice president of pumis Biotechnology Co., Ltd., announced the formal commencement of the project. Cai Chuan, vice president of the group company and head of Nantong company, attended the commencement ceremony( Nantong company)
Recommended news
2026-09-18
In mid-September, a foreign‑owned owner‑audit expert team from Jotun’s Norwegian headquarters conducted a three‑day, headquarter‑level specialized safety audit at the Jotun Zhangjiagang project site undertaken by the Group.
2026-09-18
The Roche (Shanghai) project of the Group has successfully achieved 2 million safe man-hours.
On September 17, the Roche (Shanghai) Biopharmaceutical Production Base project, undertaken by the Group, successfully reached the milestone of 2 million safe man-hours.
2026-09-18
On September 16–17, the China Chemical Construction Enterprises Association held a training course on building “Quality‑Trusted Work Teams” in Chengdu, with representatives from the Group in attendance. The training featured a live lecture by Shi Jie, a senior expert of the Association.
2026-09-09
Good News Abounds | The Group Has Secured Multiple Emerging Industry Projects in Succession
In the golden autumn season, bountiful harvests abound, and new‑generation growth sectors showcase their strength. Since August, leveraging its deep-rooted expertise and core competencies in industrial installation, the Group has successively won bids for five key projects in emerging productivity fields, with a total contract value exceeding RMB 250 million, injecting robust momentum into its resilient year‑end performance.
2026-09-03
Recently, the China Construction Industry Association announced the results of the 2026 Engineering Construction Quality Management Team Achievement Competition. Two QC projects submitted by the Group—“Improving the First-Pass Acceptance Rate for One-Time Forming of Exterior Concrete Moldings” and “Enhancing the First-Pass Welding Acceptance Rate for Dissimilar Steels”—were awarded second and third prizes, respectively.
2026-09-01
On the afternoon of August 31, the Group convened a meeting of heads of regional companies and departmental offices in the fourth-floor conference room at its headquarters to deliberate on the implementation of the spirit of the symposium for branch‑office representatives held by the Group on August 30.